Ποια είναι η τιμή για Huaren Pharmaceutical Co., Ltd. (300110)

Η τιμή για Huaren Pharmaceutical Co., Ltd. (300110) είναι $0.42025026

Ποια είναι η κεφαλαιοποίηση αγοράς για Huaren Pharmaceutical Co., Ltd. (300110)

Η κεφαλαιοποίηση αγοράς για Huaren Pharmaceutical Co., Ltd. (300110) είναι $496.83M

Huaren Pharmaceutical Co., Ltd. (300110) Τιμή και Κεφαλαιοποίηση Αγοράς

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. The company was founded in 1998 and is based in Qingdao, China.

Η τιμή για 300110	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$4,497.95 $496.83M	NVDA	$5.318T	+1,070,202.55%
$3,911.33 $496.83M	AAPL	$4.624T	+930,613.50%
$3,435.61 $496.83M	GOOG	$4.062T	+817,416.32%
$3,210.66 $496.83M	MSFT	$3.796T	+763,887.08%
$2,376.96 $496.83M	AMZN	$2.810T	+565,506.69%

Η τιμή για 300110

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$4,497.95 $496.83M